• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Conservative versus aggressive antiplatelet strategy for emergent carotid stenting during stroke thrombectomy
CONCLUSIONS: In this retrospective study, aggressive periprocedural antiplatelet strategy led to improved stent patency and clinical outcomes, without increased HT. Further prospective randomized research is warranted to identify the optimal combination of antiplatelet agents for emergent carotid stenting in the setting of acute stroke.PMID:35253529 | DOI:10.1177/15910199221083112
Source: Interventional Neuroradiology - March 7, 2022 Category: Radiology Authors: Raoul Pop Fran çois Severac Anca Hasiu Dan Mihoc Pierre H Mangin Salvatore Chibbaro Mihaela Simu Raluca Tudor Roxana Gheoca V éronique Quenardelle Val érie Wolff R émy Beaujeux Source Type: research

Ticagrelor versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms
CONCLUSION: Compared to the clopidogrel based regimen, ticagrelor can also reduce TEs without increasing bleeding tendency for SACE of UIAs. Ticagrelor combined with low-dose aspirin is a safe and effective alternative option for SACE.PMID:34792425 | DOI:10.1177/15910199211054959
Source: Interventional Neuroradiology - November 18, 2021 Category: Radiology Authors: Shuo-Chi Chien Ching-Chang Chen Chun-Ting Chen Alvin Yi-Chou Wang Po-Chuan Hsieh Mun-Chun Yeap Zhuo-Hao Liu Yu-Chi Wang Yu-Tse Liu Source Type: research

Dual energy CT in the management of antiplatelet therapy in patients with acute ischemic stroke for carotid obstruction.
CONCLUSIONS: DE-CT may contribute to select antiplatelet regimen after acute carotid stenting in tandem occlusions. PMID: 31684785 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - November 9, 2019 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Malignant stroke in a ticagrelor non-responder as a complication following aneurysm treatment with the Pipeline Embolization Device ™.
Malignant stroke in a ticagrelor non-responder as a complication following aneurysm treatment with the Pipeline Embolization Device™. Interv Neuroradiol. 2017 Jan 01;:1591019917697473 Authors: Ghamasaee P, Carr K, Johnson J, Grandhi R Abstract The Pipeline Embolization Device™ (PED; Covidien Neurovascular Inc, Irvine, CA, USA) is a flow-diverting stent often used for the endovascular treatment of large or giant, wide-necked intracranial aneurysms of the internal carotid artery. Because of the inherent thrombogenicity of intracranial stents, dual-antiplatelet therapy is initiated after placement, wh...
Source: Interventional Neuroradiology - April 11, 2017 Category: Radiology Tags: Interv Neuroradiol Source Type: research